Ozempic and Wegovy maker ‘just scratching the surface’ in meeting demand for weight loss drugs, CEO says
The CEO of Novo Nordisk, Lars Fruergaard Jorgensen, stated that it may take several years to meet the demand for the weight loss drug Wegovy, as the company struggles to keep up with the needs of over 100 million Americans with obesity.